For help on how to get the results you want, see our search tips.
55 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Paediatric investigation plans Remove Paediatric investigation plans filter
Direct healthcare professional communication Remove Direct healthcare professional communication filter
Authorisation status
Refused Remove Refused filter
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Omblastys
iodine (131I) omburtamab, Neuroblastoma
Date of refusal: 12/04/2023,
, Refused, Last updated: 14/06/2023
-
List item
Human medicine European public assessment report (EPAR): Ipique
bevacizumab, Wet Macular Degeneration
Date of refusal: 29/04/2022, Refused, Last updated: 24/05/2022 -
List item
Human medicine European public assessment report (EPAR): Raylumis
Tanezumab, Osteoarthritis; Pain
Date of refusal: 15/11/2021, Refused, Last updated: 15/02/2022 -
List item
Human medicine European public assessment report (EPAR): Nouryant
Istradefylline, Parkinson Disease
Date of refusal: 06/01/2022, Refused, Last updated: 19/01/2022 -
List item
Human medicine European public assessment report (EPAR): Gamifant
Emapalumab, Immune System Diseases
Date of refusal: 07/01/2021,, Refused, Last updated: 23/03/2021
-
List item
Human medicine European public assessment report (EPAR): Hopveus
sodium oxybate, Substance Withdrawal Syndrome; Alcohol Abstinence
Date of refusal: 06/07/2020, Refused, Last updated: 13/07/2020 -
List item
Human medicine European public assessment report (EPAR): Cabazitaxel Teva
cabazitaxel, Prostatic Neoplasms
Date of refusal: 11/07/2019, Refused, Last updated: 24/07/2019 -
List item
Human medicine European public assessment report (EPAR): Eladynos
abaloparatide, Osteoporosis
Date of refusal: 07/01/2019, Refused, Last updated: 14/02/2019 -
List item
Human medicine European public assessment report (EPAR): Dexxience
betrixaban maleate, Venous Thromboembolism
Date of refusal: 20/09/2018, Refused, Last updated: 09/10/2018 -
List item
Human medicine European public assessment report (EPAR): Alsitek
Masitinib mesilate, Amyotrophic Lateral Sclerosis
Date of refusal: 26/07/2018,, Refused, Last updated: 31/07/2018
-
List item
Human medicine European public assessment report (EPAR): Xeljanz
Tofacitinib, Arthritis, Rheumatoid Refused, Last updated: 23/07/2018 -
List item
Human medicine European public assessment report (EPAR): Masipro
Masitinib mesilate, Mastocytosis
Date of refusal: 18/12/2017,, Refused, Last updated: 04/04/2018
-
List item
Human medicine European public assessment report (EPAR): Fanaptum
iloperidone, Schizophrenia
Date of refusal: 15/01/2018, Refused, Last updated: 19/03/2018 -
List item
Human medicine European public assessment report (EPAR): Onzeald
etirinotecan pegol, Breast Neoplasms
Date of refusal: 08/01/2018, Refused, Last updated: 02/02/2018 -
List item
Human medicine European public assessment report (EPAR): EnCyzix
enclomifene citrate, Hypogonadism
Date of refusal: 06/04/2018, Refused, Last updated: 26/01/2018 -
List item
Human medicine European public assessment report (EPAR): Adlumiz
anamorelin hydrochloride, Cachexia; Anorexia; Carcinoma, Non-Small-Cell Lung
Date of refusal: 16/11/2017, Refused, Last updated: 30/11/2017 -
List item
Human medicine European public assessment report (EPAR): Human IGG1 monoclonal antibody specific for human interleukin-1 alpha XBiotech
human IgG1 monoclonal antibody specific for human interleukin-1 alpha, Colorectal Neoplasms
Date of refusal: 08/12/2017, Refused, Last updated: 13/11/2017 -
List item
Human medicine European public assessment report (EPAR): Dropcys
mercaptamine, Corneal Diseases; Cystinosis
Date of refusal: 24/06/2016,, Refused, Last updated: 25/07/2016
-
List item
Human medicine European public assessment report (EPAR): Heparesc
Human heterologous liver cells, Urea Cycle Disorders, Inborn
Date of refusal: 21/12/2015,, Refused, Last updated: 04/04/2016
-
List item
Human medicine European public assessment report (EPAR): Solumarv
insulin human, Diabetes Mellitus
Date of refusal: 11/02/2016,
, Refused, Last updated: 16/02/2016
-
List item
Human medicine European public assessment report (EPAR): Lympreva
dasiprotimut-t, Lymphoma, Non-Hodgkin
Date of refusal: 03/07/2015,, Refused, Last updated: 17/07/2015
-
List item
Human medicine European public assessment report (EPAR): Masiviera
masitinib, Pancreatic Neoplasms, Refused, Last updated: 06/01/2015
-
List item
Human medicine European public assessment report (EPAR): Reasanz
Serelaxin, Heart Failure
Date of refusal: 05/08/2014, Refused, Last updated: 01/09/2014 -
List item
Human medicine European public assessment report (EPAR): Nerventra
laquinimod, Multiple Sclerosis
Date of refusal: 19/08/2014, Refused, Last updated: 01/09/2014 -
List item
Human medicine European public assessment report (EPAR): Masican
masitinib, Gastrointestinal Stromal Tumors
Date of refusal: 04/07/2014,, Refused, Last updated: 22/11/2013